| 25 May 2026 |
ACE-031 |
5.8 |
50mg |
52.6mg |
+5.3% |
99.40% |
Lab B |
| 25 May 2026 |
Clomid |
9.3 |
25mg |
28.4mg |
+13.4% |
98.64% |
Lab D |
| 25 May 2026 |
KPV Oral |
8.5 |
25mg |
26.8mg |
+7.1% |
95.30% |
Lab G |
| 24 May 2026 |
CJC-1295 w/o DAC 5mg + IPA 5mg Blend |
7.0 |
50mg |
49.2mg |
-1.7% |
96.80% |
Lab E |
| 24 May 2026 |
Hyaluronic acid |
9.1 |
50mg |
59.7mg |
+19.3% |
97.85% |
Lab G |
| 24 May 2026 |
Propionyl chloride CAS 79-03-8 |
7.8 |
500g |
467.9g |
-6.4% |
98.16% |
Lab F |
| 24 May 2026 |
Tirzepatide |
7.6 |
30mg |
28.2mg |
-6.0% |
99.89% |
Lab E |
| 24 May 2026 |
Winstrol Oil |
5.1 |
200mg/ml |
181.4mg/ml |
-9.3% |
97.76% |
Lab E |
| 24 May 2026 |
CJC-1295 w/o DAC 5mg + IPA 5mg Blend |
6.2 |
15mg |
13.1mg |
-12.4% |
95.42% |
Lab F |
| 23 May 2026 |
Tirzepatide |
8.0 |
5mg |
5.14mg |
+2.8% |
99.90% |
Lab E |
| 23 May 2026 |
FOXO4 |
6.7 |
5mg |
4.4mg |
-11.8% |
97.88% |
Lab F |
| 23 May 2026 |
Pancragen |
8.7 |
5mg |
4.9mg |
-2.3% |
95.56% |
Lab E |
| 23 May 2026 |
Retatrutide Raw |
6.3 |
1g |
0.9g |
-13.3% |
97.10% |
Lab E |
| 23 May 2026 |
Tirzepatide |
8.0 |
20mg |
21mg |
+5.0% |
99.90% |
Lab E |
| 23 May 2026 |
BPC157 10mg + TB500 10mg Blend |
4.7 |
30mg |
30.3mg |
+1.1% |
98.36% |
Lab B |
| 23 May 2026 |
Cagrilintide 5mg + Semaglutide 5mg Blend |
7.3 |
10mg |
12.1mg |
+21.2% |
96.32% |
Lab B |
| 23 May 2026 |
Pancragen |
5.7 |
2mg |
2.0mg |
+1.9% |
95.58% |
Lab F |
| 21 May 2026 |
Tesamorelin |
7.8 |
10mg |
10.6mg |
+6.0% |
99.06% |
Lab E |
| 21 May 2026 |
BAM15 |
8.3 |
20mg |
24.6mg |
+23.0% |
95.16% |
Lab C |
| 21 May 2026 |
KPV Oral |
10.0 |
50mg |
51.4mg |
+2.7% |
95.73% |
Lab F |
| 21 May 2026 |
Tirzepatide |
8.6 |
10mg |
10.7mg |
+7.0% |
99.62% |
Lab E |
| 21 May 2026 |
Tirzepatide |
7.3 |
15mg |
15.2mg |
+1.3% |
99.61% |
Lab E |
| 21 May 2026 |
Ovagen |
8.9 |
15mg |
12.8mg |
-14.5% |
95.43% |
Lab A |
| 21 May 2026 |
SNAP-8 |
4.7 |
20mg |
22.6mg |
+12.8% |
99.98% |
Lab F |
| 20 May 2026 |
BPC157 10mg + TB500 10mg Blend |
6.4 |
10mg |
10.9mg |
+8.5% |
99.50% |
Lab E |
| 20 May 2026 |
Cagrilintide 5mg + Semaglutide 5mg Blend |
4.9 |
10mg |
11.6mg |
+16.5% |
98.64% |
Lab B |
| 20 May 2026 |
GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg |
6.0 |
15mg |
15.3mg |
+2.2% |
98.03% |
Lab F |
| 20 May 2026 |
Prednisone |
10.0 |
25mg |
31.0mg |
+24.2% |
99.32% |
Lab E |
| 20 May 2026 |
RIPEX 225 (TRA/Mast P/Test P) |
5.5 |
250mg/ml |
220.0mg/ml |
-12.0% |
97.14% |
Lab D |
| 19 May 2026 |
1-Testosterone Cypionate (DHB) Raw |
5.0 |
5g |
4.3g |
-14.2% |
99.59% |
Lab E |
| 19 May 2026 |
MOTS-C |
6.7 |
10mg |
12.2mg |
+22.1% |
95.70% |
Lab C |
| 19 May 2026 |
Tesamorelin |
7.2 |
10mg |
11.1mg |
+11.0% |
99.49% |
Lab E |
| 17 May 2026 |
KPV Oral |
7.9 |
25mg |
30.5mg |
+22.0% |
98.08% |
Lab E |
| 17 May 2026 |
Retatrutide 5mg + Cagrilintide 5mg Blend |
7.6 |
10mg |
10.8mg |
+8.5% |
99.48% |
Lab B |
| 29 Jan 2026 |
PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 |
4.4 |
10g |
12.2g |
+21.6% |
96.17% |
Lab A |
| 26 Jan 2026 |
CJC-1295 With DAC |
6.7 |
15mg |
13.0mg |
-13.1% |
99.75% |
Lab A |
| 26 Jan 2026 |
Ovagen |
7.3 |
10mg |
9.3mg |
-6.7% |
97.25% |
Lab F |
| 26 Jan 2026 |
Winstrol Oil |
4.7 |
300mg/ml |
293.9mg/ml |
-2.0% |
97.32% |
Lab A |
| 19 Jan 2026 |
BAC Water |
4.0 |
5mg |
4.4mg |
-12.7% |
97.65% |
Lab G |
| 19 Jan 2026 |
GW-501516 (Cardarine) |
8.3 |
20mg |
18.8mg |
-6.0% |
96.09% |
Lab B |
| 19 Jan 2026 |
Pancragen |
7.6 |
30mg |
37.4mg |
+24.5% |
96.74% |
Lab B |
| 19 Jan 2026 |
RIPEX 225 (TRA/Mast P/Test P) |
6.7 |
250mg/ml |
269.0mg/ml |
+7.6% |
97.51% |
Lab A |
| 19 Jan 2026 |
RIPEX 225 (TRA/Mast P/Test P) |
7.6 |
200mg/ml |
230.4mg/ml |
+15.2% |
98.02% |
Lab G |
| 9 Jan 2026 |
Prednisone |
6.0 |
100mg |
122.7mg |
+22.7% |
98.91% |
Lab B |
| 6 Jan 2026 |
PTD-DBM |
8.1 |
10mg |
9.1mg |
-9.4% |
99.03% |
Lab A |
| 29 Dec 2025 |
1-Boc-4-(2-fluorophenylamino)piperidine CAS 887583-57-5 |
7.2 |
500g |
522.9g |
+4.6% |
96.28% |
Lab A |
| 29 Dec 2025 |
1-Testosterone Cypionate (DHB) Raw |
7.3 |
10g |
8.9g |
-11.2% |
96.29% |
Lab C |
| 12 Dec 2025 |
1-Boc-4-(2-fluorophenylamino)piperidine CAS 887583-57-5 |
6.6 |
500g |
607.1g |
+21.4% |
96.52% |
Lab A |
| 12 Dec 2025 |
Ovagen |
7.1 |
50mg |
62.1mg |
+24.2% |
96.31% |
Lab D |
| 23 Nov 2025 |
ACE-031 |
6.0 |
30mg |
31.9mg |
+6.5% |
96.94% |
Lab C |
| 23 Nov 2025 |
Cagrilintide 5mg + Semaglutide 5mg Blend |
6.9 |
10mg |
8.6mg |
-14.4% |
95.18% |
Lab G |
| 17 Nov 2025 |
ACE-031 |
4.0 |
30mg |
36.4mg |
+21.4% |
98.38% |
Lab G |
| 14 Nov 2025 |
Epithalon |
8.9 |
15mg |
13.7mg |
-8.4% |
98.04% |
Lab A |
| 14 Nov 2025 |
Retatrutide Raw |
8.5 |
1g |
1.1g |
+13.4% |
98.38% |
Lab F |
| 14 Nov 2025 |
SNAP-8 |
5.9 |
5mg |
5.2mg |
+3.1% |
96.15% |
Lab E |
| 5 Nov 2025 |
SNAP-8 |
4.1 |
10mg |
9.1mg |
-8.6% |
95.46% |
Lab A |
| 5 Nov 2025 |
Tadalafil Raw |
6.7 |
100g |
87.8g |
-12.2% |
96.62% |
Lab G |
| 4 Nov 2025 |
BPC157 10mg + TB500 10mg Blend |
5.1 |
2mg |
2.2mg |
+8.6% |
95.43% |
Lab A |
| 4 Nov 2025 |
Sildenafil Raw |
9.7 |
5g |
6.1g |
+22.9% |
99.72% |
Lab A |
| 9 Oct 2025 |
T3 (Liothyronine) |
6.3 |
50mg |
61.1mg |
+22.3% |
96.43% |
Lab B |
| 9 Oct 2025 |
Telmisartan |
8.2 |
10mg |
12.4mg |
+23.8% |
95.36% |
Lab F |
| 3 Oct 2025 |
Healthy Hair Skin Nails Blend (Niacinamide+Thiamine+Pantothenic Acid+Choline+Inositol+Niacin+Biotin+Folic Acid+Riboflavin) |
6.0 |
100mg/ml |
110.5mg/ml |
+10.5% |
97.27% |
Lab E |
| 3 Oct 2025 |
NA Semax Amidate |
6.9 |
2mg |
2.2mg |
+8.2% |
98.43% |
Lab C |
| 3 Oct 2025 |
Prednisone |
5.5 |
100mg |
100.8mg |
+0.8% |
98.87% |
Lab B |